Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep;43(9):1612-1624.
doi: 10.1177/0271678X231173185. Epub 2023 Apr 27.

Isoflurane and ketamine-xylazine modify pharmacokinetics of [18F]SynVesT-1 in the mouse brain

Affiliations

Isoflurane and ketamine-xylazine modify pharmacokinetics of [18F]SynVesT-1 in the mouse brain

Alan Miranda et al. J Cereb Blood Flow Metab. 2023 Sep.

Abstract

We investigated the effect of isoflurane and ketamine-xylazine anesthesia on the positron emission tomography (PET) tracer [18F]SynVesT-1 in the mouse brain. [18F]SynVesT-1 PET scans were performed in C57BL/6J mice in five conditions: isoflurane anesthesia (ANISO), ketamine-xylazine (ANKX), awake freely moving (AW), awake followed by isoflurane administration (AW/ANISO) or followed by ketamine-xylazine (AW/ANKX) 20 min post tracer injection. ANISO, ANKX and AW scans were also performed in mice administered with levetiracetam (LEV, 200 mg/kg) to assess non-displaceable binding. Metabolite analysis was performed in ANISO, ANKX and AW mice. Finally, in vivo autoradiography in ANISO, ANKX and AW mice at 30 min post-injection was performed for validation. Kinetic modeling, with a metabolite corrected image derived input function, was performed to calculate total and non-displaceable volume of distribution (VT(IDIF)). VT(IDIF) was higher in ANISO compared to AW (p < 0.0001) while VT(IDIF) in ANKX was lower compared with AW (p < 0.0001). Non-displaceable VT(IDIF) was significantly different between ANISO and AW, but not between ANKX and AW. Change in the TAC washout was observed after administration of either isoflurane or ketamine-xylazine. Observed changes in tracer kinetics and volume of distribution might be explained by physiological changes due to anesthesia, as well as by induced cellular effects.

Keywords: [18F]SynVesT-1; isoflurane; ketamine-xylazine; mouse brain; positron emission tomography.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Regional [18F]SynVesT-1 volume of distribution (VT(IDIF)) in mice from (a) group 1 (ANISO, AW), (b) group 2 (ANISO, AW, with LEV blocking 200 mg/kg), (c) group 3 (ANKX, AW) and (d) group 4 (ANKX,AW, with LEV blocking 200 mg/kg), calculated with Logan plot. Plots y-axis scale is different.
Figure 2.
Figure 2.
Average brain [18F]SynVesT-1 VT(IDIF) maps in isoflurane anesthetized and awake mice without (a group 1) and with (b, group 2) levetiracetam (LEV) blocking (200 mg/kg). (c) Relative (to the whole brain) VT(IDIF) in mice without LEV blocking. The red arrow points to medulla region and (d) Magnetic resonance for anatomical reference.
Figure 3.
Figure 3.
Average brain [18F]SynVesT-1 VT(IDIF) maps in ketamine-xylazine anesthetized and awake mice without (a group 3) and with (b, group 4) levetiracetam (LEV) blocking (200 mg/kg). (c) Relative (to the whole brain) VT(IDIF) in mice without LEV blocking. Red arrows points to cortex and medulla and (d) Magnetic resonance for anatomical reference.
Figure 4.
Figure 4.
(a) Mean regional SUV time activity curves for ANISO, AW, and AW/ANISO conditions during 2 hours scans. (b) Mean regional SUV time activity curves for ANKX, AW, and AW/ANKX conditions during 1 hour scans. Time axis is different in column (a) and (b). CTX: cortex; CP: caudate putamen; TH: thalamus; HC: hippocampus; CB: cerebellum.
Figure 5.
Figure 5.
(a) Autoradiography regional brain quantification in animals under isoflurane, and ketamine-xylazine anesthesia, as well as in awake animals, in animals sacrificed 30 min tracer post-injection. (b) Regional brain quantification in brain PET images in ANISO, ANKX, and AW conditions, at 30 min tracer post-injection. (c) Correlation, and regression line, between brain mean regional quantification values (every point is a region), in ARG and PET at 30 min post-tracer injection, considering animals in the 3 conditions and (d) Example of brain autoradiography image and the different regions used for quantification.

References

    1. Bertoglio D, Verhaeghe J, Miranda A, et al.. Validation and noninvasive kinetic modeling of [(11)C]UCB-J PET imaging in mice. J Cereb Blood Flow Metab 2020; 40: 1351–1362. - PMC - PubMed
    1. Naganawa M, Li S, Nabulsi N, et al.. First-in-Human evaluation of (18)F-SynVesT-1, a radioligand for PET imaging of synaptic vesicle glycoprotein 2A. J Nucl Med 2021; 62: 561–567. - PMC - PubMed
    1. Li S, Naganawa M, Pracitto R, et al.. Assessment of test-retest reproducibility of [(18)F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2A. Eur J Nucl Med Mol Imaging 2021; 48: 1327–1338. - PubMed
    1. Finnema SJ, Toyonaga T, Detyniecki K, et al.. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: a [(11) C]UCB-J positron emission tomography study. Epilepsia 2020; 61: 2183–2193. - PubMed
    1. Chen MK, Mecca AP, Naganawa M, et al.. Assessing synaptic density in Alzheimer disease with synaptic vesicle glycoprotein 2A positron emission tomographic imaging. JAMA Neurol 2018; 75: 1215–1224. - PMC - PubMed

Publication types

LinkOut - more resources